Clinical trials
Not yet recruiting Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
190 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 10 |
| 2024 | 16 |
| 2025 | 45 |
| 2026 | 108 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 190 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 9 |
| The First Affiliated Hospital with Nanjing Medical University | 5 |
| Ruijin Hospital | 4 |
| Sun Yat-sen University | 4 |
| Zhujiang Hospital | 4 |
| National Taiwan University Hospital | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 2 |
| Chinese PLA General Hospital | 2 |
| Dana-Farber Cancer Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 190 |
| Multiple Myeloma | 14 |
| Lymphoma, B-Cell | 12 |
| Neoplasm Metastasis | 12 |
| Leukemia, Myeloid, Acute | 11 |
| Neoplasms | 11 |
| Lymphoma | 9 |
| Uterine Cervical Neoplasms | 9 |
| Carcinoma, Hepatocellular | 6 |
| Hematologic Neoplasms | 6 |
Trials
Showing 1 to 25 of 190. Each trial links to its page on Pharma Observatory.
90 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.